Industry
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Structured For Success… And Failure
November 2007 | Business Environment OutlookSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
BMI has overhauled the methodology for Business Environment ratings for Q108. Under the new system, the operating environment is broken down into four categories: the pharmaceutical market, country structure, market risks and country risk. Scores are directly comparable both regionally and across BMI's 61-pharmaceutical market

